| Literature DB >> 34774033 |
Faisal Khatib1, Dayana Jibrin2, Joud Al-Majali2, Mira Elhussieni2, Sharifeh Almasaid2, Mamoun Ahram3.
Abstract
BACKGROUND: Biobanks are considered primary means+ of supporting contemporary research, in order to deliver personalized and precise diagnostics with public acceptance and participation as a cornerstone for their success. AIMS: This study aims to assess knowledge, perception, and attitudes towards biomedical research and biobanking among students at the University of Jordan.Entities:
Keywords: Biobanking; Biomedical research; Genetic Research; Informed consent, Medical school; Jordan; Privacy; Research participation; University students
Mesh:
Year: 2021 PMID: 34774033 PMCID: PMC8590123 DOI: 10.1186/s12910-021-00719-y
Source DB: PubMed Journal: BMC Med Ethics ISSN: 1472-6939 Impact factor: 2.652
Sample characteristics
| Sex (N = 435) | % |
|---|---|
| Male (122) | 28.0 |
| Female (313) | 72.0 |
| Age | |
| 17 (1) | 0.2 |
| 18 (11) | 2.5 |
| 19 (124) | 28.5 |
| 20 (89) | 20.5 |
| 21 (81) | 18.6 |
| 22 (49) | 11.3 |
| 23 (54) | 12.4 |
| 24 and above (26) | 2.1 |
| Mean = 20.8 (± 2.01; Min = 17; Max = 39) | |
| School categories | |
| Medical (198) | 45.5 |
| Non-medical (237) | 54.5 |
| Health School (318) | 73.1 |
| Non-health (117) | 26.1 |
| Scientific (363) | 83.4 |
| Non-scientific (72) | 16.6 |
| Academic years | |
| Second year (154) | 35.4 |
| Third year (96) | 22.1 |
| Fourth-year and higher (185) | 42.5 |
| GPA | |
| < 2.00 (3) | 0.7 |
| 2.00–2.49 (39) | 9.0 |
| 2.50–2.99 (106) | 24.4 |
| 3.00–3.49 (144) | 33.2 |
| 3.5–4.00 (142) | 32.7 |
| Income (JD)* | |
| < 500 (38) | 8.7 |
| 500–999 (105) | 23.4 |
| 1000–1499 (71) | 15.2 |
| 1500–1999 (40) | 9.2 |
| 2000 and higher (92)r | 20.9 |
Missing data (n) = 98 (22.5%)
Knowledge of biobanking, attitudes towards the use of biospecimen in research, and engagement in research
| Questions | Responses | Significant factors associated with favorable responsea | |
|---|---|---|---|
| Yes (%) | No (%) | ||
| Have you previously participated in medical research | 112 (28.9) | 276 (71.1) | Being in medical***, health***, or scientific** schools, 3rd and 4th year, GPA of 2.50–2.99***, income > 2000 JD** |
| Have you previously heard of biobanks? | 230 (52.9) | 250 (47.1) | Being in medical***, health***, or scientific** schools, GPA of ≥ 2.50*, income of 500–1500 and > 2000 JD**, prior participation in biomedical research* |
a*P < 0.05; **P < 0.01; ***P < 0.001)
Fig. 1Preferences of biospecimens donated for research
Factors influencing participation in biomedical research
| Least level of importance (%) | Slightly important (%) | Important (%) | Very important (%) | Unsure (%) | |
|---|---|---|---|---|---|
| Time spent to participate | 23 (5.3) | 127 (29.2) | 69 (15.9) | 22 (5.1) | |
| Fear of blood and needles | 63 (14.5) | 50 (11.5) | 19 (4.4) | 19 (4.4) | |
| Consenting prior to participation | 12 (2.8) | 33 (7.6) | 148 (34.0) | 6 (1.4) | |
| Gaining direct personal benefit | 95 (21.8) | 107 (24.6) | 59 (13.6) | 37 (8.5) | |
| Religious views on participation | 23 (5.3) | 127 (29.2) | 69 (15.9) | 22 (5.1) | |
| Protection of privacy | 16 (3.7) | 38 (8.7) | 131 (30.1) | 7 (1.60 | |
| Ability of withdrawal | 67 (15.4) | 32 (7.4) | |||
| Nature of provided information | 35 (8.0) | 86 (19.8) | 16 (3.7) | ||
| Nature of family information provided | 33 (7.6) | 90 (20.7) | 14 (3.2) | ||
| Approval of an authorized ethics committee | 19 (4.4) | 56 (12.9) | 132 (30.3) | 4 (0.9) | |
| Type of research conducted | 64 (14.7) | 98 (22.5) | 120 (27.6) | 15 (3.4) | |
| Positive impact on public health | 9 (2.1) | 75 (17.2) | 12 (2.8) | ||
| Personal gain of any profit | 70 (16.1) | 21 (4.8) | 7 (1.6) | 47 (10.8) | |
| Availability of general research results | 26 (6.0) | 101 (23.2) | 130 (29.9) | 7 (1.6) | |
| Availability of personalized research results | 27 (6.2) | 84 (19.3) | 142 (32.6) | 12 (2.8) | |
| Trust towards researchers | 11 (2.5) | 61 (14.0) | 153 (35.2) | 12 (2.8) | |
| Identity of researchers | 85 (19.5) | 74 (17.0) | 39 (9.0) | 48 (11.0) |
Prominent responses are bolded
Impact of certain aspects of biobanks on willingness to participate
| Possibility of participating in a biobank under different circumstances | Strongly disagree (%) | Disagree (%) | Agree (%) | Strongly agree (%) | Unsure (%) |
|---|---|---|---|---|---|
| Overall likelihood to participate | 7 (1.7) | 25 (6.2) | 271 (67.4) | 99 (24.6) | 33 (7.5) |
| a. Lack of benefits | 13 (3.0) | 36 (8.3) | 242 (55.6) | 111 (25.5) | 33 (7.6) |
| b. Undisclosed type of research | 85 (19.5) | 161 (37.0) | 105 (24.1) | 20 (4.6) | 46 (10.6) |
| c. Unavailability of general research results | 42 (9.7) | 138 (31.7) | 175 (40.2) | 34 (7.8) | 46 (10.6) |
| d. If managed by a governmental center | 19 (4.4) | 39 (9.0) | 250 (57.5) | 80 (18.4) | 47 (10.8) |
| e. If managed by an academic institute | 8 (1.8) | 22 (5.1) | 237 (54.5) | 151 (34.7) | 17 (3.9) |
| f. If managed by a private health sector | 32 (7.4) | 66 (15.2) | 208 (47.8) | 68 (15.6) | 61 (14) |
| g. If managed by an Arab institute | 16 (3.7) | 46 (10.6) | 249 (57.2) | 83 (19.1) | 41 (9.4) |
| h. If managed by a non-Arab institute | 26 (6.0) | 63 (14.5) | 217 (49.9) | 74 (17.0) | 55 (12.6) |
Specific preferences in regards to biobanking-related aspects
| Broad consent | 138 (31.7) |
| Research-specific consent | 166 (38.2) |
| One-time consent with conditional re-contact | 131 (30.1) |
| Code biospecimens with possible re-identification | 216 (49.7) |
| Irreversibly de-identify biospecimen at a later stage upon request | 120 (27.6) |
| Irreversibly de-identify biospecimens at the time of collection | 98 (22.5) |
| Neutral | 1 (0.2) |
| Re-contact under all circumstances | 293 (67.4) |
| Re-contact me only in definite cases of having or increasing the possibility of having a disease | 100 (23.0) |
| Re-contact me only in definite cases of having or increasing the possibility of having a treatable disease | 37 (8.5) |
| Never re-contact me | 5 (1.1) |
| Disposal of biospecimens only | 31 (7.1) |
| Deleting all data only | 41 (9.4) |
| Disposal of both biospecimen and data | 225 (51.7) |
| Removing donor identifiers, but keep biospecimens and data for future research | 138 (31.7) |